Rady Children's Institute for Genomic Medicine
Stephen Kingsmore serves as the President and CEO of Rady Children's Institute for Genomic Medicine since September 2015. Prior to this role, Stephen held the Dee Lyons/Missouri Endowed Chair in Genomic Medicine at the University of Missouri-Kansas City from July 2011 to September 2015, and simultaneously directed the Center for Pediatric Genomic Medicine at Children's Mercy Hospital. Stephen has extensive experience in genomic medicine, having led initiatives that provided rapid molecular diagnoses for children with ultra-rare genetic diseases. Additional leadership roles include Chief Executive Officer of the National Center For Genome Resources, COO of Molecular Staging, and VP of Research at CuraGen. Stephen's academic background includes a D.Sc. in Systems Biology and a medical degree from Queen's University Belfast.
Rady Children's Institute for Genomic Medicine
The Rady Children's Institute for Genomic Medicine is leading the way in advancing precision healthcare for infants and children through genomic and systems medicine research. Discoveries at the Institute are enabling rapid diagnosis and targeted treatment of critically ill newborns and pediatric patients at Rady Children’s Hospital-San Diego. The vision is to expand delivery of this integrated translational research process to enable the practice of precision pediatric medicine at children’s hospitals across California, the nation and the world. RCIGM is a subsidiary of Rady Children’s Hospital and Health Center. Learn more at www.RadyGenomics.org.